🟢 Intellia Therapeutics is trading 5% up in pre-market after announcing a $400 million non-dilutive loan facility

Intellia Therapeutics is trading $13.39 (+5.10%) after announcing a $400 million non-dilutive senior secured loan facility with OrbiMed.

• $75 million was drawn initially.
• Additional milestone-linked tranches will support lonvo-z development and commercialization.
• The announcement was issued September 4 and received broader attention ahead of September 8 trading.